RGS8

RGS8 (Regulator of G-protein Signaling 8) is a member of the R4 subfamily of regulator of G-protein signaling proteins and functions as a GTPase-activating protein that accelerates GTP hydrolysis on activated Gα subunits, thereby terminating G protein-coupled receptor (GPCR) signaling cascades^[1][2]. RGS8 contains a conserved RGS domain and regulates signaling downstream of multiple GPCR pathways, including muscarinic acetylcholine receptor and dopamine receptor signaling, highlighting its role in neuronal signal transduction and cellular responsiveness^[2][3]. Mechanistically, RGS8 modulates GPCR-dependent signaling kinetics and can regulate downstream effectors such as G-protein-coupled inwardly rectifying potassium channels, calcium signaling pathways, and ERK-associated signaling networks^[3][4]. Structural studies demonstrated that RGS8 interacts with both Gα_i/o and Gα_q family proteins and adopts a conserved binding mode with Gα_q, providing an important framework for understanding G-protein selectivity among RGS family members^[5]. In disease-relevant and experimental systems, RGS8 is highly expressed in the central nervous system, particularly in cerebellar regions, and has been associated with neuronal signaling regulation and neurobiological research models^[3][6]. Compared with related isoforms such as RGS2, which exhibits distinctive Gα_q selectivity, RGS8 displays broader substrate recognition within canonical R4-family signaling mechanisms, making it a useful model for studying GPCR signal termination and G-protein regulatory specificity^[5]. Although RGS proteins are considered attractive pharmacological targets for modulating GPCR signaling, selective RGS8-directed agonists or inhibitors remain limited, and current applications primarily focus on mechanistic and signaling pathway investigations^[7].